Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrick Vink Insider Profile
4 Followers
Patrick Vink, EVP & COO at Cubist Pharma, holds 55.00K shares in Spero Therapeutics (Ticker: SPRO), holds 0.00 shares in Cubist Pharma (Ticker: CBST), holds ― shares in SQZ Biotechnologies (Ticker: SQZB).
Patrick Vink Cubist Pharma (CBST)EVP & COO
Cubist Pharma (CBST)
EVP & COO
Not Ranked
Patrick Vink has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Patrick Vink holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Patrick Vink
Patrick Vink's Trading History
Cubist Pharma
Jan 21, 2015
―
Uninformative Sell
560.59K
―
Spero Therapeutics
May 30, 2024
Director
Uninformative Buy
―
$72.05K
SQZ Biotechnologies
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Patrick Vink's performance on stock
You May Also Like
Patrick Vink insider profile FAQ
What is the percentage of profitable transactions made by Patrick Vink?
The percentage of profitable transactions made by Patrick Vink is ―.
What is the average return per transaction made by Patrick Vink?
The average return per transaction made by Patrick Vink is ―.
What stocks does Patrick Vink hold?
Patrick Vink holds: CBST, SPRO, SQZB stocks.
What was Patrick Vink’s latest transaction?
Patrick Vink latest transaction was an Uninformative Buy of ―.
What was Patrick Vink's most profitable transaction?
Patrick Vink’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Patrick Vink's role in Cubist Pharma?
Patrick Vink's role in Cubist Pharma is EVP & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.